TxCell files for Euronext IPO

Inflammatory and autoimmune disease play TxCell S.A. (Valbonne, France) filed for an IPO on NYSE Euronext. Separately, TxCell granted Ferring Pharmaceuticals A/S (Saint-Prex, Switzerland) an exclusive...